November 13, 2015
Daraprim and Vecamyl sales brings Turing $5.6 million in 3Q 2015, New Drug applications on the way
Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, reported net revenue $5.6 million for the third quarter 2015.